These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14504654)

  • 1. Pharmacogenetics and disease genetics of complex diseases.
    Schmith VD; Campbell DA; Sehgal S; Anderson WH; Burns DK; Middleton LT; Roses AD
    Cell Mol Life Sci; 2003 Aug; 60(8):1636-46. PubMed ID: 14504654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to SNPs: discovery of markers for disease.
    Weiner MP; Hudson TJ
    Biotechniques; 2002 Jun; Suppl():4-7, 10, 12-3. PubMed ID: 12083396
    [No Abstract]   [Full Text] [Related]  

  • 3. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
    Nebert DW; Zhang G; Vesell ES
    Drug Metab Rev; 2008; 40(2):187-224. PubMed ID: 18464043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of using SNPs in the understanding and treatment of disease.
    Schifreen RS; Storts DR; Buller AM
    Biotechniques; 2002 Jun; Suppl():14-6, 18, 20-1. PubMed ID: 12083392
    [No Abstract]   [Full Text] [Related]  

  • 5. SNPs: At the origins of the databases of an innovative biotechnology tool.
    Corfield A; Meyer P; Kassam S; Mikuz G; Sergi C
    Front Biosci (Schol Ed); 2010 Jan; 2(1):1-4. PubMed ID: 20036923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic genome-wide association studies: lessons learned thus far.
    Crowley JJ; Sullivan PF; McLeod HL
    Pharmacogenomics; 2009 Feb; 10(2):161-3. PubMed ID: 19207016
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics.
    Roses AD
    Hum Mol Genet; 2001 Oct; 10(20):2261-7. PubMed ID: 11673409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [I. Single nucleotide polymorphism in human genetic analyses].
    Czerska K; Nawara M; Bal J
    Med Wieku Rozwoj; 2003; 7(4 Pt 2):531-46. PubMed ID: 15213368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wealth of discovery built on the Human Genome Project - by the numbers.
    Gates AJ; Gysi DM; Kellis M; Barabási AL
    Nature; 2021 Feb; 590(7845):212-215. PubMed ID: 33568828
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogenetics.
    Stephens JC
    Mol Diagn; 1999 Dec; 4(4):309-17. PubMed ID: 10671641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.
    Chadaeva IV; Ponomarenko MP; Rasskazov DA; Sharypova EB; Kashina EV; Matveeva MY; Arshinova TV; Ponomarenko PM; Arkova OV; Bondar NP; Savinkova LK; Kolchanov NA
    BMC Genomics; 2016 Dec; 17(Suppl 14):995. PubMed ID: 28105927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targetability of human disease genes.
    Sakharkar MK; Sakharkar KR
    Curr Drug Discov Technol; 2007 Jun; 4(1):48-58. PubMed ID: 17630928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monogenic disorders - a source of novel drug targets.
    Brinkman RR; Dubé MP; Rouleau GA; Orr AC; Samuels ME
    Nat Rev Genet; 2006 Apr; 7(4):249-60. PubMed ID: 16534513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex genetic diseases: controversy over the Croesus code.
    Wright AF; Hastie ND
    Genome Biol; 2001; 2(8):COMMENT2007. PubMed ID: 11532206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospects of medicinal use of achievements in genomics: the beginning of era of complete genome medical genetics].
    Sverdlov ED
    Patol Fiziol Eksp Ter; 2001; (1):3-22. PubMed ID: 11247299
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic polymorphisms and implications for human diseases.
    Sripichai O; Fucharoen S
    J Med Assoc Thai; 2007 Feb; 90(2):394-8. PubMed ID: 17375650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics and therapeutic intervention].
    Brousseau T
    Ann Pharm Fr; 1999 Jan; 57(1):56-60. PubMed ID: 10073050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics tools for single nucleotide polymorphism discovery and analysis.
    Clifford RJ; Edmonson MN; Nguyen C; Scherpbier T; Hu Y; Buetow KH
    Ann N Y Acad Sci; 2004 May; 1020():101-9. PubMed ID: 15208187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics in drug discovery and development: challenge and promise of individualizing treatment in common complex diseases.
    Lindpaintner K
    Br Med Bull; 1999; 55(2):471-91. PubMed ID: 10723870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.